News Home

Cullinan Oncology Inc (CGEM) is down -2.57% in a Week, Should You Accumulate?

Friday, March 31, 2023 04:00 PM | InvestorsObserver Analysts

Mentioned in this article

Cullinan Oncology Inc (CGEM) is down -2.57% in a Week, Should You Accumulate?

Cullinan Oncology Inc (CGEM) is around the top of the Biotechnology industry according to InvestorsObserver. CGEM received an overall rating of 67, which means that it scores higher than 67 percent of all stocks. Cullinan Oncology Inc also achieved a score of 81 in the Biotechnology industry, putting it above 81 percent of Biotechnology stocks. Biotechnology is ranked 35 out of the 148 industries.

Overall Score - 67
CGEM has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on CGEM!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cullinan Oncology Inc Stock Today?

Cullinan Oncology Inc (CGEM) stock is trading at $10.24 as of 3:51 PM on Friday, Mar 31, an increase of $0.04, or 0.39% from the previous closing price of $10.20. Volume today is less active than usual. So far 121,318 shares have traded compared to average volume of 260,230 shares. The stock has traded between $9.99 and $10.50 so far today. Click Here to get the full Stock Report for Cullinan Oncology Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App